inebilizumab
Showing 1 - 5 of 5
Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorders
- Inebilizumab
- Rituximab(RTX)
- (no location specified)
Sep 29, 2023
Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- Inebilizumab
- oral immunosuppressant
- (no location specified)
Jun 5, 2023
Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (Inebilizumab)
Recruiting
- Neuromyelitis Optica Spectrum Disorder
- Inebilizumab
-
La Jolla, California
- +14 more
Jan 25, 2023
IgG4 Related Disease Trial in Worldwide (Inebilizumab, Placebo)
Recruiting
- IgG4 Related Disease
- Inebilizumab
- Placebo
-
Palo Alto, California
- +81 more
Oct 19, 2022
Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders Trial in Worldwide (Inebilizumab, Placebo)
Completed
- Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders
- Inebilizumab
- Placebo
-
Birmingham, Alabama
- +97 more
Nov 3, 2021